Endothelial α3β1-integrin represses pathological angiogenesis and sustains endothelial-VEGF

American Journal of Pathology

Volumn 177, Issue 3, 2010, Pages 1534-1548

  Da Silva, Rita Graça ^a,h   Tavora, Bernardo ^a   Robinson, Stephen D ^a   Reynolds, Louise E ^a   Szekeres, Charles ^b,c,d,l   Lamar, John ^e   Batista, Sílvia ^a   Kostourou, Vassiliki ^a,i   Germain, Mitchel A ^a,j   Reynolds, Andrew R ^a,k   Jones, Dylan T ^a   Watson, Alan R ^a   Jones, Janet L ^a   Harris, Adrian ^f   Hart, Ian R ^a   Iruela Arispe, M Luisa ^g   DiPersio, C Michael ^e   Kreidberg, Jordan A ^b,c,d   Hodivala Dilke, Kairbaan M ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD STEM CELL INSTITUTE   (United States)

^e ALBANY MEDICAL COLLEGE   (United States)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h HOSPITAL FOR SICK CHILDREN   (Canada)

ⁱ Biomedical Research Foundation   (Greece)

^j NOVARTIS HORSHAM RESEARCH CENTRE   (United Kingdom)

^k INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^l UNIVERSITY OF SOUTH FLORIDA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2; VERY LATE ACTIVATION ANTIGEN 3;

ANIMAL; ANOXIA; ARTICLE; CANCER TRANSPLANTATION; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; GENETICS; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MOUSE; MOUSE MUTANT; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ANIMALS; ANOXIA; BLOTTING, WESTERN; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHA3BETA1; MALE; MICE; MICE, KNOCKOUT; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 77956534675     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.100043     Document Type: Article

References (59)

1. Hodivala-Dilke KM, Reynolds AR, Reynolds LE: Integrins in angiogenesis: multitalented molecules in a balancing act. Cell Tissue Res 2003, 314:131-144
2. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L: VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol 2006, 7:359-371
3. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z: Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999, 13:9-22
4. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E, Ferrara N, Fyfe G, Rogers B, Ross R, Kabbinavar F: Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004, 350:2335-2342 (Pubitemid 38702844)
5. Sandler A, Gray R, Perry MC, Brahmer J, Schiller JH, Dowlati A, Lilenbaum R, Johnson DH: Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 2006, 355:2542-2550 (Pubitemid 44917502)
6. Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Rixe O, Oudard S, Negrier S, Szczylik C, Kim ST, Chen I, Bycott PW, Baum CM, Figlin RA: Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 2007, 356:115-124 (Pubitemid 46089672)
7. Ebos JM, Lee CR, Cruz-Munoz W, Bjarnason GA, Christensen JG, Kerbel RS: Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 2009, 15: 232-239
8. Paez-Ribes M, Allen E, Hudock J, Takeda T, Okuyama H, Vinals F, Inoue M, Bergers G, Hanahan D, Casanovas O: Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 2009, 15:220-231
9. Takeda Y, Kazarov AR, Butterfield CE, Hopkins BD, Benjamin LE, Kaipainen A, Hemler ME: Deletion of tetraspanin Cd151 results in decreased pathologic angiogenesis in vivo and in vitro. Blood 2007, 109:1524-1532 (Pubitemid 46239585)
10. Gonzalez AM, Gonzales M, Herron GS, Nagavarapu U, Hopkinson SB, Tsuruta D, Jones JC: Complex interactions between the laminin alpha 4 subunit and integrins regulate endothelial cell behavior in vitro and angiogenesis in vivo. Proc Natl Acad Sci USA 2002, 99: 16075-16080 (Pubitemid 35462751)
11. Thyboll J, Kortesmaa J, Cao R, Soininen R, Wang L, Iivanainen A, Sorokin L, Risling M, Cao Y, Tryggvason K: Deletion of the laminin alpha4 chain leads to impaired microvessel maturation. Mol Cell Biol 2002, 22:1194-1202 (Pubitemid 34094855)
12. Zhou Z, Doi M, Wang J, Cao R, Liu B, Chan KM, Kortesmaa J, Sorokin L, Cao Y, Tryggvason K: Deletion of laminin-8 results in increased tumor neovascularization and metastasis in mice. Cancer Res 2004, 64:4059-4063 (Pubitemid 38802404)
13. Borza CM, Pozzi A, Borza DB, Pedchenko V, Hellmark T, Hudson BG, Zent R: Integrin alpha3beta1, a novel receptor for alpha3(IV) noncollagenous domain and a trans-dominant Inhibitor for integrin alphavbeta3. J Biol Chem 2006, 281:20932-20939 (Pubitemid 44115434)
14. Boosani CS, Mannam AP, Cosgrove D, Silva R, Hodivala-Dilke KM, Keshamouni VG, Sudhakar A: Regulation of COX-2 mediated signaling by alpha3 type IV noncollagenous domain in tumor angiogenesis. Blood 2007, 110:1168-1177 (Pubitemid 47281413)
15. Chandrasekaran L, He CZ, Al-Barazi H, Krutzsch HC, Iruela-Arispe ML, Roberts DD: Cell contact-dependent activation of alpha3beta1 integrin modulates endothelial cell responses to thrombospondin-1. Mol Biol Cell 2000, 11:2885-2900 (Pubitemid 32107072)
16. Good DJ, Polverini PJ, Rastinejad F, Le Beau MM, Lemons RS, Frazier WA, Bouck NP: A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci USA 1990, 87:6624-6628
17. Hutchings H, Ortega N, Plouet J: Extracellular matrix-bound vascular endothelial growth factor promotes endothelial cell adhesion, migration, and survival through integrin ligation. FASEB J 2003, 17:1520-1522
18. Seo DW, Kim SH, Eom SH, Yoon HJ, Cho YR, Kim PH, Kim YK, Han JW, Diaz T, Wei BY, Stetler-Stevenson WG: TIMP-2 disrupts FGF-2- induced downstream signaling pathways. Microvasc Res 2008, 76:145-151
19. Furrer J, Luy B, Basrur V, Roberts DD, Barchi JJ, Jr.: Conformational analysis of an alpha3beta1 integrin-binding peptide from thrombospondin-1: implications for antiangiogenic drug design. J Med Chem 2006, 49:6324-6333
20. Lillo AM, Sun C, Gao C, Ditzel H, Parrish J, Gauss CM, Moss J, Felding-Habermann B, Wirsching P, Boger DL, Janda KD: A human single-chain antibody specific for integrin alpha3beta1 capable of cell internalization and delivery of antitumor agents. Chem Biol 2004, 11:897-906 (Pubitemid 38991784)
21. Kreidberg JA, Donovan MJ, Goldstein SL, Rennke H, Shepherd K, Jones RC, Jaenisch R: Alpha 3 beta 1 integrin has a crucial role in kidney and lung organogenesis. Development 1996, 122: 3537-3547 (Pubitemid 26395995)
22. Lee S, Chen TT, Barber CL, Jordan MC, Murdock J, Desai S, Ferrara N, Nagy A, Roos KP, Iruela-Arispe ML: Autocrine VEGF signaling is required for vascular homeostasis. Cell 2007, 130:691-703 (Pubitemid 47268059)
23. DiPersio CM, Shah S, Hynes RO: alpha 3A beta 1 integrin localizes to focal contacts in response to diverse extracellular matrix proteins. J Cell Sci 1995, 108:2321-2336
24. Hynes RO, Marcantonio EE, Stepp MA, Urry LA, Yee GH: Integrin heterodimer and receptor complexity in avian and mammalian cells. J Cell Biol 1989, 109:409-420
25. Marcantonio EE, Hynes RO: Antibodies to the conserved cytoplasmic domain of the integrin beta 1 subunit react with proteins in vertebrates, invertebrates, and fungi. J Cell Biol 1988, 106: 1765-1772
26. Liu Y, Chattopadhyay N, Qin S, Szekeres C, Vasylyeva T, Mahoney ZX, Taglienti M, Bates CM, Chapman HA, Miner JH, Kreidberg JA: Coordinate integrin and c-Met signaling regulate Wnt gene expression during epithelial morphogenesis. Development 2009, 136:843-853
27. Gustafsson E, Brakebusch C, Hietanen K, Fassler R: Tie-1-directed expression of Cre recombinase in endothelial cells of embryoid bodies and transgenic mice. J Cell Sci 2001, 114:671-676 (Pubitemid 32237139)
28. Reynolds LE, Hodivala-Dilke KM: Primary mouse endothelial cell culture for assays of angiogenesis. Methods Mol Med 2006, 120:503-509
29. Reynolds LE, Wyder L, Lively JC, Taverna D, Robinson SD, Huang X, Sheppard D, Hynes RO, Hodivala-Dilke KM: Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins. Nat Med 2002, 8:27-34
30. Reynolds AR, Reynolds LE, Nagel TE, Lively JC, Robinson SD, Hicklin DJ, Bodary SC, Hodivala-Dilke KM: Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling mediates enhanced angiogenesis in beta3-integrin-deficient mice. Cancer Res 2004, 64:8643-8650
31. Friedlander M, Theesfeld CL, Sugita M, Fruttiger M, Thomas MA, Chang S, Cheresh DA: Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases. Proc Natl Acad Sci USA 1996, 93:9764-9769
32. Mahadevan V, Hart IR, Lewis GP: Factors influencing blood supply in wound granuloma quantitated by a new in vivo technique. Cancer Res 1989, 49:415-419 (Pubitemid 19049536)
33. Krilleke D, Deerkenez A, Schubert W, Giri I, Robinson GS, Ng YS, Shima DT: Molecular mapping and functional characterization of the VEGF164 heparin-binding domain. J Biol Chem 2007, 282:280450-280456
34. Lee TH, Seng S, Li H, Kennel SJ, Avraham HK, Avraham S: Integrin regulation by vascular endothelial growth factor in human brain microvascular endothelial cells: role of alpha6beta1 integrin in angiogenesis. J Biol Chem 2006, 281:40450-40460 (Pubitemid 46041848)
35. Reynolds AR, Hart IR, Watson AR, Welti JC, Silva RG, Robinson SD, Da Violante G, Gourlaouen M, Salih M, Jones MC, Jones DT, Saunders G, Kostourou V, Perron-Sierra F, Norman JC, Tucker GC, Hodivala-Dilke KM: Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors. Nat Med 2009, 15:392-400
36. Hodivala-Dilke KM, McHugh KP, Tsakiris DA, Rayburn H, Crowley D, Ullman-Cullere M, Ross FP, Coller BS, Teitelbaum S, Hynes RO: Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J Clin Invest 1999, 103:229-238 (Pubitemid 29053141)
37. Nicosia RF, Ottinetti A: Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro. Lab Invest 1990, 63:115-122
38. Iljin K, Petrova TV, Veikkola T, Kumar V, Poutanen M, Alitalo K: A fluorescent Tie1 reporter allows monitoring of vascular development and endothelial cell isolation from transgenic mouse embryos. FASEB J 2002, 16:1764-1774 (Pubitemid 35340357)
39. Takahashi A, Sasaki H, Kim SJ, Kakizoe T, Miyao N, Sugimura T, Terada M, Tsukamoto T: Identification of receptor genes in renal cell carcinoma associated with angiogenesis by differential hybridization technique. Biochem Biophys Res Commun 1999, 257:855-859
40. Pierce EA, Foley ED, Smith LE: Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch Ophthalmol 1996, 114:1219-1228
41. Sonnenberg A, Janssen H, Hogervorst F, Calafat J, Hilgers J: A complex of platelet glycoproteins Ic and IIa identified by a rat monoclonal antibody. J Biol Chem 1987, 262:10376-10383
42. Prewett M, Huber J, Li Y, Santiago A, O'Connor W, King K, Overholser J, Hooper A, Pytowski B, Witte L, Bohlen P, Hicklin DJ: Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors. Cancer Res 1999, 59:5209-5218
43. Adams RH, Alitalo K: Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 2007, 8:464-478
44. Maharaj AS, Saint-Geniez M, Maldonado AE, D'Amore PA: Vascular endothelial growth factor localization in the adult. Am J Pathol 2006, 168:639-648
45. Robinson SD, Reynolds LE, Wyder L, Hicklin DJ, Hodivala-Dilke KM: Beta3-integrin regulates vascular endothelial growth factor-A-dependent permeability. Arterioscler Thromb Vasc Biol 2004, 24:2108-2114
46. Zhang Z, Ramirez NE, Yankeelov TE, Li Z, Ford LE, Qi Y, Pozzi A, Zutter MM: alpha2beta1 integrin expression in the tumor microenvironment enhances tumor angiogenesis in a tumor cell-specific manner. Blood 2008, 111:1980-1988
47. Robinson SD, Reynolds LE, Kostourou V, Reynolds AR, da Silva RG, Tavora B, Baker M, Marshall JF, Hodivala-Dilke KM: Alphav beta3 integrin limits the contribution of neuropilin-1 to vascular endothelial growth factor-induced angiogenesis. J Biol Chem 2009, 284:33966-33981
48. Germain M, De Arcangelis A, Robinson SD, Baker M, Tavora B, D'Amico G, Silva R, Kostourou V, Reynolds LE, Watson A, Jones JL, Georges-Labouesse E, Hodivala-Dilke K: Genetic ablation of the alpha 6-integrin subunit in Tie1Cre mice enhances tumour angiogenesis. J Pathol 2010, 220:370-381
49. Hierck BP, Poelmann RE, van Iperen L, Brouwer A, Gittenberger-de Groot AC: Differential expression of alpha-6 and other subunits of laminin binding integrins during development of the murine heart. Dev Dyn 1996, 206:100-111
50. Shiojiri N, Sugiyama Y: Immunolocalization of extracellular matrix components and integrins during mouse liver development. Hepatology 2004, 40:346-355
51. Wu JE, Santoro SA: Differential expression of integrin alpha subunits supports distinct roles during lung branching morphogenesis. Dev Dyn 1996, 206:169-181
52. Seo DW, Li H, Guedez L, Wingfield PT, Diaz T, Salloum R, Wei BY, Stetler-Stevenson WG: TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism. Cell 2003, 114:171-180
53. Hiran TS, Mazurkiewicz JE, Kreienberg P, Rice FL, LaFlamme SE: Endothelial expression of the alpha6beta4 integrin is negatively regulated during angiogenesis. J Cell Sci 2003, 116:3771-3781
54. Lee C, Dixelius J, Thulin A, Kawamura H, Claesson-Welsh L, Olsson AK: Signal transduction in endothelial cells by the angiogenesis inhibitor histidine-rich glycoprotein targets focal adhesions. Exp Cell Res 2006, 312:2547-2556
55. Nikolopoulos SN, Blaikie P, Yoshioka T, Guo W, Giancotti FG: Integrin beta4 signaling promotes tumor angiogenesis. Cancer Cell 2004, 6:471-483
56. Goumans MJ, Lebrin F, Valdimarsdottir G: Controlling the angiogenic switch: a balance between two distinct TGF-b receptor signaling pathways. Trends Cardiovasc Med 2003, 13:301-307
57. Al-Nedawi K, Meehan B, Kerbel RS, Allison AC, Rak J: Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc Natl Acad Sci USA 2009, 106:3794-3799
58. Shiose S, Sakamoto T, Yoshikawa H, Hata Y, Kawano Y, Ishibashi T, Inomata H, Takayama K, Ueno H: Gene transfer of a soluble receptor of VEGF inhibits the growth of experimental eyelid malignant melanoma. Invest Ophthalmol Vis Sci 2000, 41:2395-2403
59. Bates DO, Cui TG, Doughty JM, Winkler M, Sugiono M, Shields JD, Peat D, Gillatt D, Harper SJ: VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Res 2002, 62:4123-4131